CAS 19660-77-6

Codes: TALAS-001

Application context (from source-drug indications)

Lung cancerTalaporfin Sodium脑癌Talaporfin Sodium脉络膜新生血管化Talaporfin Sodium年龄相关性黄斑变性Talaporfin SodiumPort-wine stainTalaporfin SodiumBenign prostatic hyperplasiaTalaporfin Sodium

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Talaporfin Sodium	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Talaporfin SodiumOriginator routesteps: 3total yield: /

TALAS-001→(S)-di-tert-butyl 2-aminosuccinate hydrochloride→TALAS-003

Talaporfin SodiumOptimised routesteps: 2total yield: /

TALAS-001→21H-9,12-Imino-2,22-metheno-7,4:14,17-dinitrilo-1H-oxepino[4,5-b]azacyclononadecine-16-propanoic acid, 10-ethenyl-5-ethyl-15,16,18,19-tetrahydro-6,11,15,23-tetramethyl-19,21-dioxo-, (15S,16S)-→(S)-2-aminosuccinic acid

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.